101
|
Rodriguez-Abreu D, Wu YL, Boyer M, Garassino M, Mok T, Cheng Y, Hui R, Kowalski D, Robinson A, Brahmer J, Leal T, Lopes G, Cho B, Nogami N, Novello S, Peled N, de Castro G, Leiby M, Chirovsky D, Lin J, Pietanza M, Reck M. OA15.06 Pooled Analysis of Outcomes with Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
102
|
Zheng Y, Niu F, Jiang P, Zhu X, Lin J, Wu X, Qin L, Liu Z, Fang S, Jin C, Yu X, Zuo L. 1039P Efficacy and safety of surufatinib (HMPL-012) as a third-line or further treatment for advanced non-small cell lung cancer (NSCLC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
103
|
Soulieres D, Harrington K, Le Tourneau C, Silva J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Lin J, Lerman N, Gumuscu B, Cohen E. 658MO Pembrolizumab (pembro) vs standard-of-care (SOC) in previously treated recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 6-year follow-up of KEYNOTE-040. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
104
|
Shi W, Huang C, Chen S, Yang C, Liu N, Zhu X, Su X, Zhu X, Lin J. Long-term exposure to air pollution increases hip fracture incidence rate and related mortality: analysis of National Hip Fracture Database. Osteoporos Int 2022; 33:1949-1955. [PMID: 35654856 DOI: 10.1007/s00198-022-06445-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/15/2021] [Accepted: 05/24/2022] [Indexed: 11/25/2022]
Abstract
UNLABELLED To explore the association of air pollution and hip fracture and related mortality in the UK. The average levels of PM2.5, PM10, and NO2 exhibited a positive association with hip fracture and short-term mortality while O3 did not. Our study highlights the association of air pollution and hip fracture. INTRODUCTION Until now, the influence of air pollution on bone mineral density and associated fractures has drawn little attention, and the consequences are controversial. To investigate the association between air pollution and hip fracture incidence and related short-term mortality. METHODS We constructed a cohort of all the National Hip Fracture Database beneficiaries (513,540 patients) in the UK from 2013 to 2018. Per year averages of PM2.5, PM10, O3, NO2, and SO2 were estimated according to the person's residence. The incidence rate ratio with 95% confidence interval and all-cause mortality within 30-day post-fracture (ACM30D) rate ratios were estimated using generalized additive models. RESULTS The average levels of PM2.5, PM10, and NO2 exhibited a positive association with the incidence rate of hip fracture (IHF) and ACM30D. Whereas, this association was negative for O3 levels. Each increase of 5 μg per cubic meter in PM2.5, PM10, and NO2 leads to 9.5%, 9.2%, and 4.1% higher hip fracture rate, respectively, and also 9.3%, 8.3%, and 2.9% higher ACM30D, respectively. When we restricted the analysis to low-level exposure of air pollutants, similar results were obtained. CONCLUSION Our study found a moderate, positive association between IHF, ACM30D, and the levels of specific air pollutants in the entire National Hip Fracture Database population. A reduction in the levels of PM2.5, PM10, and NO2 may decrease the hip fracture incidence rate and associated short-term mortality in older adults. Our study highlights the influence of air pollution on hip fracture.
Collapse
Affiliation(s)
- W Shi
- Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, 215006, Jiangsu, China
| | - C Huang
- Department of Orthopeadics, China-Japan Friendship Hospital, Beijing, China
| | - S Chen
- College of medical imaging, Dalian Medical University, Dalian, China
| | - C Yang
- Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, 215006, Jiangsu, China
| | - N Liu
- Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, 215006, Jiangsu, China
| | - X Zhu
- Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, 215006, Jiangsu, China
| | - X Su
- Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, 215006, Jiangsu, China
| | - X Zhu
- Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, 215006, Jiangsu, China.
| | - J Lin
- Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Suzhou, 215006, Jiangsu, China.
- Department of Orthopaedic Surgery, Suzhou Dushu Lake Hospital, Dushu Lake Hospital Affiliated to Soochow University, Medical Center of Soochow University, Suzhou, China.
| |
Collapse
|
105
|
Lee J, Sepesi B, Toloza E, Lin J, Pass H, Johnson B, Heymach J, Johnson M, Ding B, Schulze K, Zhu Q, Ngiam C, Brandão E, Bara I, Chaft J. EP02.04-005 Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ NSCLC. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.390] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
106
|
Wu L, Pu X, Lin G, Xiao M, Lin J, Wang Q, Kong Y, Yan X, Xu F, Xu Y, Li J, Li K, Chen B, Wen X, Tan Y. EP08.01-094 A Phase II Study of Camrelizumab combined with Apatinib and Albumin Paclitaxel in Advanced Non-squamous NSCLC (CAPAP-lung). J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
107
|
Tahara M, Greil R, Rischin D, Harrington K, Burtness B, De Castro G, Psyrri A, Brana I, Neupane P, Bratland Å, Fuereder T, Hughes B, Mesia Nin R, Ngamphaiboon N, Rordorf T, Wan Ishak W, Lin J, Gumuscu B, Lerman N, Soulieres D. 659MO Pembrolizumab with or without chemotherapy for first-line treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 5-year results from KEYNOTE-048. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
108
|
Lin J, Schäfer M, Indris S, Janek J, Kondrakov A, Brezesinski T, Strauss F. A polycationic substituted lithium argyrodite superionic solid electrolyte. Acta Cryst Sect A 2022. [DOI: 10.1107/s2053273322092476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/19/2023]
|
109
|
Xiang YL, Huang SH, Hu QH, Wang QY, Zhao MQ, Jiang YC, Chen X, Lin J, Zhou QH. Zwitterionic meso-silica/polypeptide hybrid nanoparticles for efficient azithromycin delivery and photodynamic therapy for synergistic treatment of drug-resistant bacterial infection. Int J Biol Macromol 2022; 219:597-610. [PMID: 35952811 DOI: 10.1016/j.ijbiomac.2022.08.022] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2022] [Revised: 07/22/2022] [Accepted: 08/05/2022] [Indexed: 12/21/2022]
Abstract
The treatment of drug-resistant bacterial infections attributed to the overuse of antibiotics still remains a serious challenge globally. Herein, zwitterionic charge switchable meso-silica/polypeptide hybrid nanoparticles (MSPNs) were prepared for the synergistic chemo-photodynamic therapy in the treatment of drug-resistant bacterial infections. Subsequently, azithromycin (AZT) and methylene blue (MB) were loaded in the MSPNs to form the combined chemo-photodynamic therapeutic nanoparticles (MSPNs-AZT/MB) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). Remarkably, the as-prepared MSPNs-AZT/MB exhibited a negative surface charge of -5.2 mV at physiological pH while switching into positive surface charge of 24.7 mv in an acidic environment, leading to enhanced binding with bacterial surface. The lipase-triggered AZT release up to 77.9 % was achieved, and the loaded MB demonstrated efficient singlet oxygen (1O2) generation for photodynamic therapy. The in vitro experimental results displayed an excellent antibacterial effect against MRSA in both planktonic and biofilm phenotypes. Additionally, the as-prepared MSPNs-AZT/MB exhibited synergistic and enhanced antibacterial infection effect up to 94 % comparing to monotherapy in a mice model. Considering the above advantages, the as-prepared combined chemo-photodynamic therapeutic nanoparticles showed promising biocompatibility and clinical potential for the efficient therapy of drug-resistant bacteria.
Collapse
Affiliation(s)
- Ya-Li Xiang
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China
| | - Shuang-Hui Huang
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China
| | - Qiu-Hui Hu
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China
| | - Qiu-Yue Wang
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China
| | - Mei-Qi Zhao
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China
| | - Yu-Chen Jiang
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China
| | - Xiao Chen
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China
| | - Juan Lin
- School of Biomedical Sciences and Technology, Chengdu Medical College, Xindu Road No.783, Chengdu, Sichuan 610500, China.
| | - Qing-Han Zhou
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China; Key Laboratory of General Chemistry of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
| |
Collapse
|
110
|
Wang QY, Yali-Xiang, Hu QH, Huang SH, Lin J, Zhou QH. Surface charge switchable nano-micelle for pH/redox-triggered and endosomal escape mediated co-delivery of doxorubicin and paclitaxel in treatment of lung adenocarcinoma. Colloids Surf B Biointerfaces 2022; 216:112588. [PMID: 35623260 DOI: 10.1016/j.colsurfb.2022.112588] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2022] [Revised: 05/13/2022] [Accepted: 05/17/2022] [Indexed: 12/13/2022]
Abstract
Recently, the stimulus-sensitive drug co-delivery system has gained increasing attentions in the clinic and exhibits improved efficiency rather than the mono-chemotherapy in anti-tumor therapy. Herein, the smart charge switchable nano-micelles (NMs) were fabricated for the endosomal escape mediated co-delivery of doxorubicin (DOX) and paclitaxel (PTX) in treatment of lung adenocarcinoma. The disulfide bonds were facilitated as the linker of the polymer backbone to achieve the redox-sensitive degradation by high intracellular GSH, and acid-liable DMMA was grafted onto DOX molecules for pH-triggered drug release under acidic tumoral microenvironment. Folic acid (FA) was utilized as targeting molecule for facilitating entry of the as prepared NMs into cancer cells. Remarkably, the as fabricated NMs exhibited surface charge-switch from negative to positive during transmitting from physiological pH to the tumor extracellular pH, which can improve the cellular internalization towards cancer cell. Subsequently, the "proton-sponge" effect mediated endosome escape of the NMs was facilitated in the acidic endo/lysosome environment. By the cell assay, the NMs possessed good biocompatibility, excellent cellular uptake, and improved inhibition rate against cancer cell. Moreover, the co-delivery of DOX/PTX exhibited synergistic and enhanced solid tumor inhibition efficiency comparing to mono-chemotherapy in A-549 tumor bearing mice model. Based on above experimental results, the as prepared drug co-delivery system showed promising biosafety and potentials for efficient lung adenocarcinoma treatment in clinic.
Collapse
Affiliation(s)
- Qiu-Yue Wang
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China
| | - Yali-Xiang
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China
| | - Qiu-Hui Hu
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China
| | - Shuang-Hui Huang
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China
| | - Juan Lin
- School of Biomedical Sciences and Technology, Chengdu Medical College, Xindu Road No.783, Chengdu, Sichuan 610500, China.
| | - Qing-Han Zhou
- Key Laboratory of Pollution Control Chemistry and Environmental Functional Materials for Qinghai-Tibet Plateau of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, First Ring Road, 4th Section No.16, Chengdu, Sichuan 610041, China; Key Laboratory of General Chemistry of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, Chengdu 610041, China.
| |
Collapse
|
111
|
Luo Y, Rao Y, Gu X, Chai P, Yang Y, Lin J, Xu X, Jia R, Xu S. Novel MSH6 mutation predicted metastasis in eyelid and periocular squamous cell carcinoma. J Eur Acad Dermatol Venereol 2022; 36:2331-2342. [PMID: 35855666 DOI: 10.1111/jdv.18454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2021] [Accepted: 06/03/2022] [Indexed: 11/28/2022]
Abstract
BACKGROUND Our previous research revealed the relative local aggressiveness of eyelid and periocular squamous cell carcinoma (EPSCC), but its distinct genetic characteristics involved remain unknown. OBJECTIVES We conducted this study based on next-generation sequencing to identify the genetic distinctiveness of EPSCC and damaging mutations for possible etiology and poor prognosis. METHODS We performed sequencing using a 556-gene panel (smartonco) in 48 EPSCCs. Cox hazards model was applied to explore mutated genes that increase risk of metastasis and death. Pathogenesis of the mutations was predicted by sequence alignment algorithms. RESULTS The most commonly mutated genes were KMT2C (N=17, 35%), LRP1B (N=14, 29%), KMT2D (N=12, 25%), PTCH1(N=10, 21%) and TP53(N=10, 21%). DNA mismatch repair (MMR) genes (42%) like MSH6(19%) and MLH3(12%) were among the most frequently mutated genes. Cell cycle regulators including TP53(21%) and CDKN2A (10%) were less frequently mutated than in other squamous cell carcinomas (SCCs). Ultra violet exposure, MMR deficiency and aging were the main etiology. Of note, KMT2C has a deleterious mutation hotspot. Patients burdened with MSH6 mutation has a higher risk of overall metastasis (P=0.045, HR=5.165) and nodal metastasis (P=0.022, HR=14.038). Moreover, a hotspot mutation MSH6E52A brought an even higher risk of nodal metastasis (P=0.011, HR=18.745). CONCLUSIONS EPSCCs displayed a unique mutation profile from cutaneous SCCs and mucosal SCCs. We have identified novel damaging mutations in epigenetic regulators like KMT2C boosted early onset of EPSCCs in addition to UVR, aging or MMR deficiency. And malfunction of MMR genes worsened prognosis.
Collapse
Affiliation(s)
- Y Luo
- Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.,Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
| | - Y Rao
- Department of pathology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China
| | - X Gu
- Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.,Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
| | - P Chai
- Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.,Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
| | - Y Yang
- Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.,Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
| | - J Lin
- Department of pathology, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China
| | - X Xu
- Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.,Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
| | - R Jia
- Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.,Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
| | - S Xu
- Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.,Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
| |
Collapse
|
112
|
Lin LH, Lin J, Yan JY. Interactive Affection of Pre-Pregnancy Overweight or Obesity, Excessive Gestational Weight Gain and Glucose Tolerance Test Characteristics on Adverse Pregnancy Outcomes Among Women With Gestational Diabetes Mellitus. Front Endocrinol (Lausanne) 2022; 13:942271. [PMID: 35872998 PMCID: PMC9301308 DOI: 10.3389/fendo.2022.942271] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2022] [Accepted: 06/07/2022] [Indexed: 12/16/2022] Open
Abstract
Purpose To examine the combined effect of pre-pregnancy overweight or obesity, excessive gestational weight gain, and glucose tolerance status on the incidence of adverse pregnancy outcomes among women with gestational diabetes mellitus. Methods A observational study including 5529 gestational diabetes mellitus patients was performed. Logistic regression were used to assess the independent and multiplicative interactions of overweight or obese, excessive gestational weight gain, abnormal items of oral glucose tolerance test and adverse pregnancy outcomes. Additive interactions were calculated using an Excel sheet developed by Anderson to calculate relative excess risk. Results Overall 1076(19.46%) study subject were overweight or obese and 1858(33.60%) women gained weight above recommended. Based on IADPSG criteria, more than one-third women with two, or three abnormal glucose values. Preconception overweight or obesity, above recommended gestational weight gain, and two or more abnormal items of oral glucose tolerance test parameters significantly increased the risk of adverse pregnancy outcomes, separately. After accounting for confounders, each two of overweight or obesity, excessive gestational weight gain, two or more abnormal items of OGTT parameters, the pairwise interactions on adverse pregnancy outcomes appear to be multiplicative. Coexistence of preconception overweight or obesity, above recommended gestational weight gain and two or more abnormal items of oral glucose tolerance test parameters increased the highest risk for adverse pregnancy outcomes. No additive interaction was found. Conclusions Pre-pregnancy overweight or obesity, excessive gestational weight gain, two or more abnormal items of OGTT parameters contribute to adverse pregnancy outcomes independently among women with gestational diabetes mellitus. Additionally, the combined effect between these three factors and adverse pregnancy outcomes appear to be multiplicative. Interventions focus on maternal overweight or obesity and gestational weight gain should be offered to improve pregnancy outcomes.
Collapse
Affiliation(s)
- Li-hua Lin
- Department of Healthcare, Fujian Maternity and Child Health Hospital, Fuzhou, China
| | - Juan Lin
- Department of Obstetrics, Fujian Maternity and Child Health Hospital, Fuzhou, China
| | - Jian-ying Yan
- Department of Obstetrics, Fujian Maternity and Child Health Hospital, Fuzhou, China
| |
Collapse
|
113
|
Kost Y, Mieczkowska K, Deutsch A, Nazarian R, Muskat A, Hosgood D, Lin J, Shinoda K, Daily J, Kabarriti R, Ohri N, McLellan B. Bacterial decolonization to prevent acute radiation dermatitis: A randomized controlled trial. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.17_suppl.lba12003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
LBA12003 Background: Radiation dermatitis (RD) secondary to radiation therapy (RT) to treat cancer reduces quality of life (QoL) and can lead to treatment interruption. The exact etiology of RD is unknown, and bacteria play a role in other inflammatory dermatoses. As our group recently showed nasal colonization with Staphylococcus aureus (SA) prior to RT was an independent predictor of grade ≥2 RD, we conducted a randomized controlled trial evaluating efficacy of bacterial decolonization (BD) to prevent RD and improve QoL. Methods: This is a randomized phase II trial comparing BD to standard of care (SC) for adult patients with breast cancer or head and neck cancer to receive fractionated (≥ 15 fractions) RT. Patients were randomized 1:1 to the BD intervention of intranasal mupirocin ointment twice daily and chlorhexidine body wash once daily for 5 consecutive days before RT start and repeated for 5 days every other week during RT or the SC arm of emollient use as needed. The primary endpoint was development of grade ≥2 RD using Criteria for Adverse Events v4.03, and planned sample size was 80 patients. Evaluation of a preliminary cohort showed wide variability of disease in grade 2 RD, so grade 2 RD was further differentiated for more refined statistical analysis: “moderate to brisk erythema” defined as grade 2 and “patchy moist desquamation” defined as grade 2 with moist desquamation (2-MD). The secondary endpoint was patient-reported QoL assessed via the SKINDEX-16 (SD-16) questionnaire before and after RT. Bacterial culture swabs of the nares and skin at RT beginning, middle, and end were obtained for both groups. Results: 80 patients were randomized 1:1 to each arm (40 BD, 40 SC) June 2019-August 2021. 78 breast and 2 head and neck cancer patients were enrolled instead of the projected 40 of each cancer type. 76 patients were included for analysis (38 BD, 38 SC). Clinical and demographic characteristics were well balanced between arms. We demonstrated prevention of RD grades 2-MD or higher in the BD arm compared to the SC arm (0/38, 0% vs 9/38, 23.68%; P=0.002). Additionally, BD resulted in a significantly lower median RD grade compared to SC (1.19±0.7 vs 1.58±0.75, P=0.019). Finally, a linear regression model showed a significant association between BD and decreased RD grade (estimate=-0.431, 95% CI: -0.7516, -0.1054; p=0.010), even when adjusting for other RD risk factors. Most patients reported no difficulty with BD and only one patient discontinued due to itch. There was no difference in QoL outcomes between arms. Conclusions: Our results support the use of a BD regimen to prevent moist desquamation in patients receiving RT for breast or head and neck cancer. Our study included mainly breast cancer patients; thus BD efficacy needs to be tested in other solid tumors receiving RT. This is the first study demonstrating efficacy of BD to reduce RD. Given the safety and availability of this regimen, we suggest adding BD to RD prophylaxis protocols. Clinical trial information: NCT03883828.
Collapse
Affiliation(s)
- Yana Kost
- Department of Medicine, Division of Dermatology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
| | - Karolina Mieczkowska
- Department of Medicine, Division of Dermatology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
| | - Alana Deutsch
- Department of Medicine, Division of Dermatology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
| | - Roya Nazarian
- Department of Medicine, Division of Dermatology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
| | - Ahava Muskat
- Department of Medicine, Division of Dermatology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
| | | | - Juan Lin
- Albert Einstein College of Medicine, Bronx, NY
| | | | | | - Rafi Kabarriti
- Albert Einstein College of Medicine/ Montefiore Medical Center, Bronx, NY
| | - Nitin Ohri
- Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY
| | - Beth McLellan
- Department of Medicine, Division of Dermatology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
| |
Collapse
|
114
|
Huang SY, Lin J. [Correlation of periodontitis and oculopathy]. Zhonghua Kou Qiang Yi Xue Za Zhi 2022; 57:642-647. [PMID: 35692010 DOI: 10.3760/cma.j.cn112144-20220228-00080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
With the development of researches on the relationship between periodontal health and general health, more and more evidences showed that periodontitis was closely related to oculopathy, while the mechanisms were not very clear at present. This article will focus on the influences of periodontitis on the occurrence and development of various oculopathy such as diabetic retinopathy and senile macular degeneration, and discuss the possible mechanisms of the influence by periodontitis. This will provide a theoretical basis for the new ideas on prevention and treatment of oculopathy.
Collapse
Affiliation(s)
- S Y Huang
- Department of Stomatology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - J Lin
- Department of Stomatology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| |
Collapse
|
115
|
Weinstein C, Govoni M, Lin J, Meehan A, Qureshi Z. POS0947 LONG-TERM GOLIMUMAB PERSISTENCE: 5-YEAR TREATMENT RETENTION DATA POOLED FROM FIVE PHASE III CLINICAL TRIALS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.4385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundTumor necrosis factor-alpha inhibitors (TNFi), such as golimumab (GLM), are widely prescribed for treatment of chronic immune-mediated rheumatic diseases, such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS). Long-term persistence of GLM response in these diseases has previously been described from individual randomized controlled trials.1-5 While treatment retention is considered an important factor for disease progression, health care utilization, and overall quality of life, and has previously been described, the probability of retention on GLM treatment in these trials has not been evaluated.ObjectivesTo evaluate probability of GLM treatment retention over a 5-year period in adult patients with immune-mediated rheumatic diseases, by indication and line of therapy, using pooled data from five Phase III randomized controlled clinical trials.MethodsUsing data prospectively collected from five Phase III studies, this post-hoc analysis evaluated subcutaneous (SC) GLM (50 mg or 100 mg every 4 weeks) for up to 5 years in participants with RA (GO-BEFORE,1,6 GO-AFTER2,7 and GO-FORWARD3,8), PsA (GO-REVEAL4,9), and AS (GO-RAISE5,10). Four of the five studies (GO-BEFORE, GO-FORWARD, GO-REVEAL and GO-RAISE) were pooled to examine 1st-line GLM therapy, while the remaining study (GO-AFTER) was used to examine 2nd-line (i.e., ≥ 1 line) GLM therapy in participants who had previously received and discontinued at least one other TNFi (etanercept, adalimumab, or infliximab) for any reason. Log-rank tests were performed to estimate retention rates by indication and line of therapy. Similarly, Kaplan-Meier analysis was used to estimate the probability of GLM retention over time.ResultsAmong the 2228 participants enrolled in the 5 trials, 1797 participants had received GLM as1st-line treatment (RA = 1050; PsA = 394; AS = 353) and 431 participants had received GLM as 2nd-line treatment. Compared to the pooled 1st-line GLM analysis cohort, more participants receiving 2nd-line GLM were female (78.7% vs 62.2%), were > 50 years (61.5% vs 41.2%), and had a longer disease duration (median of 9.2 years vs 3.7 years). In the pooled 1st-line studies, GLM treatment retention remained high over five years, with an overall probability of retention of 87.8% (95% confidence interval [CI], 86.2–89.2) at Year 1 (Week 52), 80.9% (79.0–82.6) at Year 2 (Week 104), 77.3% (75.3–79.2) at Year 3 (Week 156), 73.5% (71.4–75.5) at Year 4 (Week 208) and 69.8% (67.6–71.9) at Year 5 (Week 252). GLM retention rates were similar across the four 1st-line GLM studies with no notable differences observed by indication over time (Figure 1, panel A). Treatment retention was better in participants using GLM as a 1st-line therapy compared to 2nd-line therapy (Figure 1, panel B), with a probability of retention at 5 years (Week 252) with 2nd-line therapy of 41.6% (95% CI: 36.8-46.3).Figure 1.ConclusionIn this post-hoc analysis of prospectively collected clinical trial data, the probability of 1st-line GLM treatment retention at 5-years was consistently high across all rheumatic indications (RA, PsA and AS). Probability of long-term GLM treatment retention with 2nd-line therapy, while lower than 1st-line therapy, also remained favorable. Collectively, these data support the value of GLM as a 1st- or 2nd-line therapy in these chronic immune-mediated rheumatic diseases.References[1]Emery P, et al. Arthritis Rheum 2009;60:2272-83.[2]Smolen JS, et al. Lancet 2009;374:210-21.[3]Keystone EC, et al. J Rheumatol. 2015;43:298-306.[4]Kavanaugh A, et al. Ann Rheum Dis. 2014;73:1689-94[5]Inman RD, et al. Arthritis Rheum 2008;58:3402-12.[6]Emery P, et al. Arthritis Care Res. 2016;68:744-52.[7]Smolen JS, et al. Arthritis Res Ther. 2015;17:14.[8]Keystone EC, et al. Ann Rheum Dis 2009;68:789-96.[9]Kavanaugh A, et al. Arthritis Rheum 2009;60:976-86.[10]Deodhar A, et al. Ann Rheum Dis. 2015;74:757-61.Disclosure of InterestsCindy Weinstein Shareholder of: Merck & Co., Inc., Kenilworth, NJ, USQA, Employee of: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, Marinella Govoni Shareholder of: Merck & Co., Inc., Kenilworth, NJ, USA, Employee of: MSD Italy, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, Jianxin Lin Shareholder of: Merck & Co., Inc., Kenilworth, NJ, USA, Employee of: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, Alan Meehan Shareholder of: Merck & Co., Inc., Kenilworth, NJ, USA, Employee of: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, Zaina Qureshi Shareholder of: Merck & Co., Inc., Kenilworth, NJ, USA, Employee of: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
Collapse
|
116
|
Wang LC, Xu L, Su BM, Xu XQ, Lin J. An Effective Chemo-Enzymatic method with An Evolved L-Threonine Aldolase for Preparing L-threo-4-Methylsulfonylphenylserine Ethyl Ester of High Optical Purity. Molecular Catalysis 2022. [DOI: 10.1016/j.mcat.2022.112355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
117
|
Zou YW, Li QH, Gao JW, Pan J, Ma JD, Chen LF, Lin J, Mo Y, Zhang X, Liu PM, Dai L. AB0276 COMPARISON OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN IDENTIFYING CARDIOVASCULAR RISK IN CHINESE INDIVIDUALS WITH RHEUMATOID ARTHRITIS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.2999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundThe nomenclature from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) is considered to identify more cardiovascular disease (CVD) risk in general population, and patients with rheumatoid arthritis (RA) carry an excess risk for CVD.ObjectivesTo compare MAFLD with NAFLD in identifying CVD risk in RA patients.MethodsClinical data from a Chinese RA cohort were retrospectively analyzed. Hepatic steatosis was defined by abdominal ultrasound examination. CVD risk in RA patients was estimated by the Prediction for Atherosclerotic Cardiovascular Disease Risk in China.ResultsAmong 513 included RA patients, 78.4% were female and the mean ± SD age was 51.8 ± 12.6 years. The prevalence of MAFLD and NAFLD was 21.4% and 20.5%, respectively. 10.9% RA patients concomitated with CVD events and 32.4% had a high 10-year CVD risk. Multivariate logistic regression analysis showed that both MAFLD and NAFLD were associated with an increase in CVD events (MAFLD: AOR = 2.303 [95% CI 1.197, 4.429]; NAFLD: AOR = 2.478 [95% CI 1.185, 4.779] and high 10-year CVD risk (MAFLD: AOR = 3.184 [95% CI 1.777, 5.705]; NAFLD: AOR = 2.870 [95% CI 1.597, 5.156]; all p < 0.05). The NRI and IDI was -0.011 (95% CI -0.025, 0.003) and -0.002 (95% CI -0.007, 0.002) for CVD events, and 0.012 (95% CI -0.014, 0.038) and 0.005 (95% CI -0.003, 0.013; all p > 0.05) for high 10-year CVD risk, which indicated no additional CVD events and high 10-years CVD risk were identified when replacing NAFLD with MAFLD in RA patients.ConclusionBoth MAFLD and NAFLD are associated with an increased CVD risk which implies the importance of early detection and management of MAFLD or NAFLD in RA patients. However, new nomenclature of MAFLD identify no additional CVD risk in RA patients.Financial support:National Natural Science Foundation of China (No. 81971527, 82171780 and 82101892), Science and Technology Program of Guangzhou (No. 202102010188 and 201904010088), and Guangdong Basic and Applied Basic Research Foundation (No. 2019A1515011928 and 2020A1515110061).Figure 1.The prevalence of MAFLD and NAFLD in RA patients with different stratification.The prevalence in different genders (A) and ages groups (B); The prevalence in different disease activity groups (C) and disease duration (D); remission (CDAI ≤ 2.8); active (CDAI > 2.8).Disclosure of InterestsNone declared
Collapse
|
118
|
Kaplan RC, Song RJ, Lin J, Xanthakis V, Hua S, Chernofsky A, Evenson KR, Walker ME, Cuthbertson C, Murabito JM, Cordero C, Daviglus M, Perreira KM, Gellman M, Sotres-Alvarez D, Vasan RS, Xue X, Spartano NL, Mossavar-Rahmani Y. Predictors of incident diabetes in two populations: framingham heart study and hispanic community health study / study of latinos. BMC Public Health 2022; 22:1053. [PMID: 35619100 PMCID: PMC9137165 DOI: 10.1186/s12889-022-13463-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Accepted: 05/12/2022] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND Non-genetic factors contribute to differences in diabetes risk across race/ethnic and socioeconomic groups, which raises the question of whether effects of predictors of diabetes are similar across populations. We studied diabetes incidence in the primarily non-Hispanic White Framingham Heart Study (FHS, N = 4066) and the urban, largely immigrant Hispanic Community Health Study/Study of Latinos (HCHS/SOL, N = 6891) Please check if the affiliations are captured and presented correctly. METHODS Clinical, behavioral, and socioeconomic characteristics were collected at in-person examinations followed by seven-day accelerometry. Among individuals without diabetes, Cox proportional hazards regression models (both age- and sex-adjusted, and then multivariable-adjusted for all candidate predictors) identified predictors of incident diabetes over a decade of follow-up, defined using clinical history or laboratory assessments. RESULTS Four independent predictors were shared between FHS and HCHS/SOL. In each cohort, the multivariable-adjusted hazard of diabetes increased by approximately 50% for every ten-year increment of age and every five-unit increment of body mass index (BMI), and was 50-70% higher among hypertensive than among non-hypertensive individuals (all P < 0.01). Compared with full-time employment status, the multivariable-adjusted hazard ratio (HR) and 95% confidence interval (CI) for part-time employment was 0.61 (0.37,1.00) in FHS and 0.62 (0.41,0.95) in HCHS/SOL. Moderate-to-vigorous physical activity (MVPA) was an additional predictor in common observed in age- and sex-adjusted models, which did not persist after adjustment for other covariates (compared with MVPA ≤ 5 min/day, HR for MVPA level ≥ 30 min/day was 0.48 [0.31,0.74] in FHS and 0.74 [0.56,0.97] in HCHS/SOL). Additional predictors found in sex- and age-adjusted analyses among the FHS participants included male gender and lower education, but these predictors were not found to be independent of others in multivariable adjusted models, nor were they associated with diabetes risk among HCHS/SOL adults. CONCLUSIONS The same four independent predictors - age, body mass index, hypertension and employment status - were associated with diabetes risk across two disparate US populations. While the reason for elevated diabetes risk in full-time workers is unclear, the findings suggest that diabetes may be part of the work-related burden of disease. Our findings also support prior evidence that differences by gender and socioeconomic position in diabetes risk are not universally present across populations.
Collapse
Affiliation(s)
- Robert C Kaplan
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue. Belfer building, Room 1315, Bronx, NY, 10461, USA.
- Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
| | - Rebecca J Song
- Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA
| | - Juan Lin
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue. Belfer building, Room 1315, Bronx, NY, 10461, USA
| | - Vanessa Xanthakis
- Department of Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Simin Hua
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue. Belfer building, Room 1315, Bronx, NY, 10461, USA
| | | | - Kelly R Evenson
- Department of Epidemiology Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Maura E Walker
- Department of Health Sciences, Boston University College of Health & Rehabilitation Sciences, Boston, MA, USA
| | - Carmen Cuthbertson
- Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Joanne M Murabito
- Department of Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Christina Cordero
- Department of Psychology, Don Soffer Clinical Research Center, University of Miami, Miami, FL, USA
| | - Martha Daviglus
- Institute for Minority Health Research, University of Illinois at Chicago, Chicago, IL, USA
| | - Krista M Perreira
- Department of Social Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA
| | - Marc Gellman
- Department of Psychology, University of Miami, Miami, FL, USA
| | - Daniela Sotres-Alvarez
- Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | | | - Xiaonan Xue
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue. Belfer building, Room 1315, Bronx, NY, 10461, USA
| | - Nicole L Spartano
- Department of Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Yasmin Mossavar-Rahmani
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue. Belfer building, Room 1315, Bronx, NY, 10461, USA
| |
Collapse
|
119
|
Zheng HL, Lin J, Huang CM. [Technical difficulties and countermeasures of digestive tract reconstruction in robotic radical gastrectomy for gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 2022; 25:392-395. [PMID: 35599393 DOI: 10.3760/cma.j.cn441530-20220304-00083] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
There still remain some problemsin digestive tract reconstruction after robotic radical gastrectomy for gastric cancer at present, such as great surgical difficulties and high technical requirements. Based on the surgical experience of the Gastric Surgery Department of Union Hospital, Fujian Medical University and the literatures at home and abroad, relevant issues are discussed in terms of robotic radical distal gastrectomy (Billroth I, Billroth II, and Roux-en-Y gastrojejunostomy), proximal gastrectomy (double-channel and double-muscle flap anastomosis), and total gastrectomy (Roux-en-Y anastomosis, functional end-to-end anastomosis, FEEA, π-anastomosis, Overlap anastomosis, and modified Overlap anastomosis with delayed amputation of jejunum, i.e. later-cut Overlap). This article mainly includes (1) The principles of digestive tract reconstruction after robotic radical gastrectomy for gastric cancer. (2) Digestive tract reconstruction after robotic radical distal gastrectomy: Aiming at the weakness of traditional triangular anastomosis, we introduce the improvement of the technical difficulty, namely "modified triangular anastomosis", and point out that because Billroth II anastomosis is a common anastomosis method in China at present, manual suture under robot is more convenient and safe, and can effectively avoid anastomotic stenosis. (3) Digestive tract reconstruction after robotic proximal gastrectomy: It mainly includes double channel anastomosis and double muscle flap anastomosis, but these reconstruction methods are relatively complicated, and robotic surgery has not been widely carried out at present. (4) Digestive tract reconstruction after robotic total gastrectomy: The most classic one is Roux-en-Y anastomosis, mainly using circular stapler for end-to-side esophagojejunal anastomosis and linear stapler for side-to-side esophagojejunal anastomosis, for which we discuss the solutions to the existing technical difficulties. With the continuous innovation of robotic surgical system and anastomosis instruments, and with the gradual improvement of anastomosis technology, it is believed that digestive tract reconstruction after robotic radical gastrectomy for gastric cancer will have a good application prospect in gastric cancer surgery.
Collapse
Affiliation(s)
- H L Zheng
- Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China
| | - J Lin
- Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China
| | - C M Huang
- Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China
| |
Collapse
|
120
|
Tang AJ, Tang FY, Ouyang ZM, Lin J, Yang ZH, Yang LJ, Wei XN, Li QH, Liang JJ, Zheng DH, Dai L, Mo YQ. OP0163 A MATRIX PREDICTION MODEL FOR THE SIX-MONTH MORTALITY RISK IN PATIENTS WITH ANTI-MELANOMA DIFFERENTIATION-ASSOCIATED PROTEIN-5 POSITIVE DERMATOMYOSITIS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.3009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BackgroundRecently, the autoantibody recognizing melanoma differentiation-associated gene 5 (anti-MDA5) is of the greatest concern as a specific autoantibody of dermatomyositis (DM), since it delineates a unique clinical phenotype of DM with a high risk of life-threatening lung complications. Considering routine clinical characteristics at baseline are still desired candidates for screening potential mortality predictors, in order to as early as possible stratify the mortality risk in anti-MDA5 positive DM patients before making therapeutic strategies.ObjectivesTo investigate the baseline independent risk factors for predicting 6-month mortality of anti-MDA5-positive DM patients and develop a matrix prediction model formed by these risk factors.MethodsThis was a real-world prospective observational study. The hospitalized patients with DM were included if they fulfilled the criteria including: aged over 18 years old; diagnosed as having DM according to the criteria proposed by Bohan and Peter or the modified Sontheimer definitions; and positive anti-MDA5 which was determined by both line immunoassay testing and enzyme-linked immunosorbent testing. The primary outcome was all-cause 6-month mortality after enrolment. A matrix prediction model was built with the mortality risk probability.ResultsThere were 82 DM patients enrolled (mean age of onset 50±11 years and 63% female), with 40 (49%) showing positive anti-MDA5. Gottron sign/papules (OR: 5.135, 95%CI: 1.489~17.708), arthritis (OR: 5.184, 95%CI: 1.455~18.467), interstitial lung disease (ILD, OR: 7.034, 95%CI: 1.157~42.785), and higher level of C4 (OR: 1.010, 95%CI: 1.002~1.017) were independent associators with positive anti-MDA5 in DM patients. Anti-MDA5-positive DM patients had significant higher 6-month all-cause mortality than those with anti-MDA5-negative (30% vs. 0%). Among anti-MDA5-positive DM patients, compared to the survivors, non-survivors had significantly advanced age of onset (59±6 years vs. 46±9 years), higher rates of fever (75% vs. 18%), positive carcinoma embryonic antigen (CEA, 75% vs. 14%), higher level of ferritin (median 2858 ug/L vs. 619 ug/L, all p<0.05). Multivariate COX regression showed ferritin≥1250 μg/L (HR: 10.4, 95%CI: 1.8~59.9), fever (HR: 11.2, 95%CI: 2.5~49.9), and positive CEA (HR: 5.2, 95%CI: 1.0~25.7) were independent risk factors of 6-month mortality.According to the matrix prediction model, anti-MDA5-positive DM patients could be stratified into three subgroups based on various probabilities of predicted mortality: (i) High-risk: eight patients with two of the above three features (including fever, serum ferritin≥1250 μg/L, and positive CEA) had high predicted mortality probability with 64%~85% (three red grids in Figure 1A), and the actual mortality was 75% (n=6) with 60%, 100%, and 100% respectively in three red grids (Figure 1B). Five patients with all of three features had extremely high predicted mortality probability with 97% (95%CI: 70%~100%, the dark red grid of Figure 1A), and the actual mortality was 100% in Figure 1B; (ii) Moderate-risk: nine patients with one of the above three features had moderate predicted mortality probability with 11%~29% (three yellow grids in Figure 1A), and the actual mortality was 11% (n=1) with 0%, 0%, and 17% respectively in three yellow grids (Figure 1B); (iii) Low-risk: eighteen patients with none of the above three features had low predicted mortality probability with 2% (95%CI: 0.2%~20%, the green grid in Figure 1A), and the actual mortality was 0% in the green grid (Figure 1B).ConclusionBaseline characteristics of fever, positive CEA, and ferritin≥1250 μg/L are risk factors for 6-month all-cause mortality in anti-MDA5-positive DM patients. A novel matrix prediction model composed of these three clinical indicators is firstly proposed to provide a chance for exploration of individual treatment strategies in anti-MDA5-positive DM subgroups with various probabilities of mortality risk.Disclosure of InterestsNone declared
Collapse
|
121
|
Zhou X, Bao WA, Zhu X, Lin J, Fan JF, Yang Y, Du XH, Wang YZ. 3,3'-Diindolylmethane attenuates inflammation and fibrosis in radiation-induced lung injury by regulating NF-κB/TGF-β/Smad signaling pathways. Exp Lung Res 2022; 48:103-113. [PMID: 35594367 DOI: 10.1080/01902148.2022.2052208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVE This study aims to investigate the protective effect of 3,3'-diindolylmethane (DIM) on the radiation-induced lung injury (RILI) model and to explore its possible mechanism. Methods: A mouse model of RILI was established by thoracic irradiation, and dexamethasone was used as a positive drug to investigate the effect of DIM on RILI mice. Lung histopathology was analyzed by HE staining and Masson staining. Then the levels of inflammatory cytokines (TGF-β, TNF-α, IL-1β, and IL-6), inflammatory cell counts, and activity of MPO were detected. The expression of TGFβ1/Smad signaling pathway-related proteins was determined by immunohistochemistry. qPCR was used to analyze the mRNA expression levels of inflammatory factors, α‑SMA and COL1A1. The expression of COX-2, NF-κB, IκBα, PI3K, and Akt proteins was assessed by Western blot. Results: Histopathological staining of lung tissues showed that DIM administration alleviated the pulmonary inflammation and fibrosis caused by RILI. Moreover, the content of inflammatory factors such as IL-1β and IL-6, the expression of NF-κB pathway-related proteins, and the counts of inflammatory cells were inhibited in lung tissue, indicating that DIM can inhibit the NF-κB pathway to reduce inflammation. In addition, DIM could down-regulate the mRNA levels of α-SMA, COL1A1, and downregulate TGFβ1, Smad3, and p-Smad2/3 in lung tissues. Conclusion: Our study confirms that DIM has the potential to treat RILI in vivo by inhibiting fibrotic and inflammatory responses in lung tissue through the TGFβ/Smad and NF-κB dual pathways, respectively.
Collapse
Affiliation(s)
- Xia Zhou
- Department of Radiation Therapy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang Province, China.,Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang Province, China
| | - Wu-An Bao
- Department of Radiation Therapy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang Province, China
| | - Xiang Zhu
- Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang Province, China
| | - Juan Lin
- Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang Province, China
| | - Ju-Fen Fan
- Department of Radiation Therapy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang Province, China
| | - Yang Yang
- Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang Province, China
| | - Xiang-Hui Du
- Department of Radiation Therapy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang Province, China.,Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang Province, China
| | - Yue-Zhen Wang
- Department of Radiation Therapy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang Province, China.,Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang Province, China
| |
Collapse
|
122
|
Kim G, Pastoriza JM, Qin J, Lin J, Karagiannis GS, Condeelis JS, Yothers G, Anderson S, Julian T, Entenberg D, Rohan TE, Xue X, Sparano JA, Oktay MH. Racial disparity in distant recurrence-free survival in patients with localized breast cancer: A pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials. Cancer 2022; 128:2728-2735. [PMID: 35578919 DOI: 10.1002/cncr.34241] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 01/25/2022] [Accepted: 01/26/2022] [Indexed: 12/31/2022]
Abstract
BACKGROUND Black race is associated with worse outcome in patients with breast cancer. The distant relapse-free survival (DRFS) between Black and White women with localized breast cancer who participated in National Cancer Institute-sponsored clinical trial was evaluated. METHODS Pooled data were analyzed from 8 National Surgical Adjuvant Breast and Bowel Project (NSABP) trials including 9702 women with localized breast cancer treated with adjuvant chemotherapy (AC, n = 7485) or neoadjuvant chemotherapy (NAC, n = 2217), who self-reported as Black (n = 1070) or White (n = 8632) race. The association between race and DRFS was analyzed using log-rank tests and multivariate Cox regression. RESULTS After adjustment for covariates including age, tumor size, nodal status, body mass index and taxane use, and treatment (AC vs NAC), Black race was associated with an inferior DRFS in estrogen receptor-positive (ER+; hazard ratio [HR], 1.24; 95% CI, 1.05-1.46; P = .01), but not in ER- disease (HR, 0.97; 95% CI, 0.83-1.14; P = .73), and significant interaction between race and ER status was observed (P = .03). There was no racial disparity in DRFS among patients with pathologic complete response (pCR) (log-rank P = .8). For patients without pCR, Black race was associated with worse DRFS in ER+ (HR, 1.67; 95% CI, 1.14-2.45; P = .01), but not in ER- disease (HR, 0.91; 95% CI, 0.65-1.28; P = .59). CONCLUSIONS Black race was associated with significantly inferior DRFS in ER+ localized breast cancer treated with AC or NAC, but not in ER- disease. In the NAC group, racial disparity was also observed in patients with residual ER+ breast cancer at surgery, but not in those who had pCR. LAY SUMMARY Black women with breast cancer have worse outcomes compared with White women. We investigated if this held true in the context of clinical trials that provide controlled treatment setting. Black women with cancer expressing estrogen receptors (ERs) had worse outcome than White women. If breast cancers did not express ERs, there was no racial disparity in outcome. We also observed racial disparity in women who received chemotherapy before their cancer was removed, but only if they had cancer expressing ERs and residual disease on completion of treatment. If the cancer disappeared with presurgical chemotherapy, there was no racial disparity.
Collapse
Affiliation(s)
- Gina Kim
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
- Department of Surgery, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
| | - Jessica M Pastoriza
- Department of Surgery, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
| | - Jiyue Qin
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
| | - Juan Lin
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
| | - George S Karagiannis
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
- Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical center, Bronx, New York
- Integrated Imaging Program, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
| | - John S Condeelis
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
- Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical center, Bronx, New York
- Integrated Imaging Program, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
| | - Greg Yothers
- Department of Biostatistics, Graduate School of Public, Health at University of Pittsburgh, Pittsburgh, Pennsylvania
- NRG Oncology, Philadelphia, Pennsylvania
| | - Stewart Anderson
- Department of Biostatistics, Graduate School of Public, Health at University of Pittsburgh, Pittsburgh, Pennsylvania
- NRG Oncology, Philadelphia, Pennsylvania
| | - Thomas Julian
- NRG Oncology, Philadelphia, Pennsylvania
- Department of Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania
| | - David Entenberg
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
- Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical center, Bronx, New York
- Integrated Imaging Program, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
| | - Thomas E Rohan
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
| | - Xiaonan Xue
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
| | - Joseph A Sparano
- Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York
| | - Maja H Oktay
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
- Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine/Montefiore Medical center, Bronx, New York
- Integrated Imaging Program, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
- Department of Pathology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York
| |
Collapse
|
123
|
Andriano TM, Benesh G, Babbush KM, Hosgood HD, Lin J, Cohen SR. Serum inflammatory markers and leukocyte profiles accurately describe hidradenitis suppurativa disease severity. Int J Dermatol 2022; 61:1270-1275. [PMID: 35543428 DOI: 10.1111/ijd.16244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Revised: 02/28/2022] [Accepted: 04/19/2022] [Indexed: 01/08/2023]
Abstract
BACKGROUND Inflammatory markers and leukocyte profiles have not been longitudinally evaluated as objective signs of hidradenitis suppurativa (HS) severity. We sought to assess C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), interleukin-6 (IL-6), and leukocyte profiles as reliable indicators of HS severity. METHODS Retrospective cohort study of 404 patients seen at the Einstein/Montefiore HS Center, Bronx, New York, between March 2019 and November 2020. Associations of disease severity (HS-Physician Global Assessment) with inflammatory markers and leukocyte profiles were assessed by odds ratios (OR) and 95% confidence intervals (95% CI) incorporating up to four visits per patient, adjusting for baseline gender, age, BMI, and smoking status. RESULTS Patients with severe disease had elevated CRP (OR 1.87; 95% CI 1.49, 2.34), ESR (OR 1.04; 95% CI 1.03, 1.04), IL-6 (OR 1.08; 95% CI 1.00, 1.16), leukocytes (OR 1.22; 95% CI 1.14, 1.31), neutrophils (OR 1.31; 95% CI 1.20, 1.42), eosinophils (OR 14.40; 95% CI 2.97, 69.74), basophils (OR 2.53; 95% CI 1.09, 5.85), monocytes (OR 5.36; 95% CI 2.49, 11.53), and neutrophil-lymphocyte ratios (OR 1.63; 95% CI 1.35, 1.96) but decreased lymphocytes (OR 0.86; 95% CI 0.68, 1.10). CONCLUSIONS This novel longitudinal study of inflammatory markers and leukocyte profiles offers critical laboratory measures to confirm clinically determined disease severity over time.
Collapse
Affiliation(s)
- Tyler M Andriano
- Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
| | - Gabrielle Benesh
- Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
| | - Kayla M Babbush
- Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
| | - H Dean Hosgood
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Juan Lin
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
| | - Steven R Cohen
- Division of Dermatology, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
| |
Collapse
|
124
|
Chang Y, Kuo C, Lin J. PO-1074 Prognostic factors analysis of carcinoma ex pleomorphic adenoma of major salivary glands. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03038-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
125
|
Lin Y, Lin J, Chang T, Chou T, Hung L, Huang C. PO-1329 Predictive factors for pathologic good response after the neoadjuvant CRT of rectal cancer. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03293-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
126
|
Lee J, Lin J, Chang C, Chen Y, Wu M. PD-0908 Anatomy- versus margin-based prophylactic para-aortic radiotherapy in cervical cancer. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02987-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
127
|
Xu LL, Luo HR, Shi XJ, Pang HP, Li JQ, Wang YM, Luo SM, Lin J, Yu HB, Xiao Y, Li X, Huang G, Xie ZG, Zhou ZG. [Identification of rare variants in exons of NLRC4 gene in patients with type 1 diabetes and their impact on gene function]. Zhonghua Yi Xue Za Zhi 2022; 102:1216-1223. [PMID: 35462504 DOI: 10.3760/cma.j.cn112137-20210803-01725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To identify rare variants in exon and exon-intron boundary of containing NLR family CARD domain protein 4 (NLRC4) in type 1 diabetes (T1DM) patients, and to explore their effects on gene function. Methods: A total of 508 T1DM patients and 527 healthy controls in the Department of Metabolic Endocrinology, Second Xiangya Hospital of Central South University from August 2017 to September 2020 were selected. The case group included 264 males and 244 females, and the age [M (Q1, Q3)] was [27 (11, 43)] years. The control group included 290 males and 237 females, and their age[M(Q1,Q3)]was [47 (36, 60)] years old. Identification of rare variants in exons of NLRC4 gene in T1DM patients and healthy controls was performed and verified by next-generation sequencing and sanger sequencing. The NLRC4 gene wild-type and mutant plasmids were constructed and transfected into 293T cells. Western blot (WB) was used to detect the expression of NLRC4 protein and cleavage products of pro-cysteinyl aspartate specific proteinase(procaspase-1). Cycloheximide (CHX) was added to 293T cells transfected with wild-type or mutant NLRC4 plasmid to detect the degradation of NLRC4 protein. The localization of NLRC4 protein was detected by immunofluorescence, and the concentration of IL-1β in the cell supernatant was detected by enzyme-linked immunosorbent assay (ELISA). Results: The sequencing results showed that 4 patients and 2 healthy controls had a heterozygous variant c.208C>T in exon 3 of the NLRC4 gene. Two patient had a heterozygous variant c.1564T>C in exon 4, and 1 patients had c.1219G>C in exon 4. These three variants might be pathogenic variants in T1DM. In 293T cells transfected with NLRC4 wild-type and c.208C>T、c.1564T>Cc.1219G>C mutant plasmids, the expression level, degradation rate, localization of NLRC4 protein and the content of cleavage products of procaspase-1 did not change significantly. However, the concentration of IL-1β secreted by 293T cells transfected with c.1219G>C and c.208C>T plasmid [M(Q1, Q3)] was 15.25 (12.98, 17.52) and 15.44 (13.81, 17.07) ng/L, respectively, which was lower than 18.70 (16.59, 20.81) ng/L of 293T cells transfected wild-type plasmid (P=0.020, 0.010). Conclusions: NLRC4 gene rare variants c.208C>T, c.1564T>C and c.1219G>C may not change the protein expression, degradation and localization, but c.208C>T and c.1219G>C may inhibit the secretion of IL-1β. This result suggests that NLRC4 rare variants may have an impact on gene function.
Collapse
Affiliation(s)
- L L Xu
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - H R Luo
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - X J Shi
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - H P Pang
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - J Q Li
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - Y M Wang
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - S M Luo
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - J Lin
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - H B Yu
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - Y Xiao
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - X Li
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - G Huang
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - Z G Xie
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| | - Z G Zhou
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospital of Central South University, Changsha 410011, China
| |
Collapse
|
128
|
Xue Z, Lu J, Lin J, Huang CM, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Zheng CH. [Establishment of artificial neural network model for predicting lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 2022; 25:327-335. [PMID: 35461201 DOI: 10.3760/cma.j.cn441530-20220105-00010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To establish a neural network model for predicting lymph node metastasis in patients with stage II-III gastric cancer. Methods: Case inclusion criteria: (1) gastric adenocarcinoma diagnosed by pathology as stage II-III (the 8th edition of AJCC staging); (2) no distant metastasis of liver, lung and abdominal cavity in preoperative chest film, abdominal ultrasound and upper abdominal CT; (3) undergoing R0 resection. Case exclusion criteria: (1) receiving preoperative neoadjuvant chemotherapy or radiotherapy; (2) incomplete clinical data; (3) gastric stump cancer.Clinicopathological data of 1231 patients with stage II-III gastric cancer who underwent radical surgery at the Fujian Medical University Union Hospital from January 2010 to August 2014 were retrospectively analyzed. A total of 1035 patients with lymph node metastasis were confirmed after operation, and 196 patients had no lymph node metastasis. According to the postoperative pathologic staging. 416 patients (33.8%) were stage Ⅱ and 815 patients (66.2%) were stage III. Patients were randomly divided into training group (861/1231, 69.9%) and validation group (370/1231, 30.1%) to establish an artificial neural network model (N+-ANN) for the prediction of lymph node metastasis. Firstly, the Logistic univariate analysis method was used to retrospectively analyze the case samples of the training group, screen the variables affecting lymph node metastasis, determine the variable items of the input point of the artificial neural network, and then the multi-layer perceptron (MLP) to train N+-ANN. The input layer of N+-ANN was composed of the variables screened by Logistic univariate analysis. Artificial intelligence analyzed the status of lymph node metastasis according to the input data and compared it with the real value. The accuracy of the model was evaluated by drawing the receiver operating characteristic (ROC) curve and obtaining the area under the curve (AUC). The ability of N+-ANN was evaluated by sensitivity, specificity, positive predictive values, negative predictive values, and AUC values. Results: There were no significant differences in baseline data between the training group and validation group (all P>0.05). Univariate analysis of the training group showed that preoperative platelet to lymphocyte ratio (PLR), preoperative systemic immune inflammation index (SII), tumor size, clinical N (cN) stage were closely related to postoperative lymph node metastasis. The N+-ANN was constructed based on the above variables as the input layer variables. In the training group, the accuracy of N+-ANN for predicting postoperative lymph node metastasis was 88.4% (761/861), the sensitivity was 98.9% (717/725), the specificity was 32.4% (44/136), the positive predictive value was 88.6% (717/809), the negative predictive value was 84.6% (44/52), and the AUC value was 0.748 (95%CI: 0.717-0.776). In the validation group, N+-ANN had a prediction accuracy of 88.4% (327/370) with a sensitivity of 99.7% (309/310), specificity of 30.0% (18/60), positive predictive value of 88.0% (309/351), negative predictive value of 94.7% (18/19), and an AUC of 0.717 (95%CI:0.668-0.763). According to the individualized lymph node metastasis probability output by N+-ANN, the cut-off values of 0-50%, >50%-75%, >75%-90% and >90%-100% were applied and patients were divided into N0 group, N1 group, N2 group and N3 group. The overall prediction accuracy of N+-ANN for pN staging in the training group and the validation group was 53.7% and 54.1% respectively, while the overall prediction accuracy of cN staging for pN staging in the training group and the validation group was 30.1% and 33.2% respectively, indicating that N+-ANN had a better prediction than cN stage. Conclusions: The N+-ANN constructed in this study can accurately predict postoperative lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer. The N+-ANN based on individualized lymph node metastasis probability has better accurate prediction for pN staging as compared to cN staging.
Collapse
Affiliation(s)
- Z Xue
- Department of Gastric Surgery, Key Laboratory of Gastrointestinal Cancer (Ministry of Education), Fujian Medical University Union Hospital, Fuzhou 350004, China
| | - J Lu
- Department of Gastric Surgery, Key Laboratory of Gastrointestinal Cancer (Ministry of Education), Fujian Medical University Union Hospital, Fuzhou 350004, China
| | - J Lin
- Department of Gastric Surgery, Key Laboratory of Gastrointestinal Cancer (Ministry of Education), Fujian Medical University Union Hospital, Fuzhou 350004, China
| | - C M Huang
- Department of Gastric Surgery, Key Laboratory of Gastrointestinal Cancer (Ministry of Education), Fujian Medical University Union Hospital, Fuzhou 350004, China
| | - P Li
- Department of Gastric Surgery, Key Laboratory of Gastrointestinal Cancer (Ministry of Education), Fujian Medical University Union Hospital, Fuzhou 350004, China
| | - J W Xie
- Department of Gastric Surgery, Key Laboratory of Gastrointestinal Cancer (Ministry of Education), Fujian Medical University Union Hospital, Fuzhou 350004, China
| | - J B Wang
- Department of Gastric Surgery, Key Laboratory of Gastrointestinal Cancer (Ministry of Education), Fujian Medical University Union Hospital, Fuzhou 350004, China
| | - J X Lin
- Department of Gastric Surgery, Key Laboratory of Gastrointestinal Cancer (Ministry of Education), Fujian Medical University Union Hospital, Fuzhou 350004, China
| | - Q Y Chen
- Department of Gastric Surgery, Key Laboratory of Gastrointestinal Cancer (Ministry of Education), Fujian Medical University Union Hospital, Fuzhou 350004, China
| | - C H Zheng
- Department of Gastric Surgery, Key Laboratory of Gastrointestinal Cancer (Ministry of Education), Fujian Medical University Union Hospital, Fuzhou 350004, China
| |
Collapse
|
129
|
Zhu X, Zhou M, Li AQ, Lin J. Solitary fibrous tumour of the sacrum: A report of 2 cases with review of the literature. Malays J Pathol 2022; 44:101-109. [PMID: 35484892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
INTRODUCTION Solitary fibrous tumour (SFT) of the sacrum is a very rare disease. So far, there have been few reports on this disease. Here, we reported 2 such cases and reviewed the other 7 reports in the literature. CASE SERIES Case 1, a 48-year-old man presented with lumbosacral pain for 2 months and numbness in the left plantar region for more than 1 month. The report of CT scan indicated that the sacrum was destroyed and the soft tissue mass projected into the pelvis. Histopathology showed that the cells were fusiform or short fusiform, arranged in strips, sheets, and wavy patterns. Case 2, a 40-year-old woman presented with hip joint pain and lower extremity dyskinesia for more than 2 months. The result of the MRI examination demonstrated a mass on the right sacral foramen and anterior sacrum. The characteristics of histopathology are ovoid or spindle-shaped cells with focal nuclear pleomorphism and prominently branched, hemangiopericytoma-like vascular patterns. In addition, immunohistochemical showed that CD34, Bcl-2, CD99, STAT6 and vimentin were positive, while Desmin, MSA, EMA, S100 were negative in both cases. CONCLUSION Previous literatures have revealed that SFTs of the sacrum are rare neoplasms. Case 1 and a part of these lesions previously reported seem to be malignant and should be treated with surgery. Radiation or chemotherapy was adopted if necessary. Since SFT of the sacrum is prone to recur and metastasis, long-term follow-up should be considered. To a certain extent, new risk stratification models can predict prognosis more accurately.
Collapse
Affiliation(s)
- X Zhu
- Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Department of Pathology, Shanghai 200080, China
| | - M Zhou
- Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Department of Pathology, Shanghai 200032, China
| | - A Q Li
- Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Department of Pathology, Shanghai 200080, China
| | - J Lin
- Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Department of Pathology, Shanghai 200080, China.
| |
Collapse
|
130
|
Lin J, Ginsberg D, Doumanian L, Boyd S, Loh-Doyle J. Preventing Urinary Fistulae After Artificial Urinary Sphincter Removal: Outcomes of a Standardized Protocol. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.01.198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
131
|
Christopoulos P, Prawitz T, Hong JL, Lin H, Hernandez L, Jin S, Tan M, Proskorovsky I, Lin J, Zhang P, Patel J, Ou SH, Thomas M, Stenzinger A. 36P Indirect comparison of mobocertinib trial data vs real-world data in patients with EGFR exon 20 insertion (ex20ins)+ non-small cell lung cancer (NSCLC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.02.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
132
|
Andreev V, Arratia M, Baghdasaryan A, Baty A, Begzsuren K, Belousov A, Bolz A, Boudry V, Brandt G, Britzger D, Buniatyan A, Bystritskaya L, Campbell AJ, Cantun Avila KB, Cerny K, Chekelian V, Chen Z, Contreras JG, Cunqueiro Mendez L, Cvach J, Dainton JB, Daum K, Deshpande A, Diaconu C, Eckerlin G, Egli S, Elsen E, Favart L, Fedotov A, Feltesse J, Fleischer M, Fomenko A, Gal C, Gayler J, Goerlich L, Gogitidze N, Gouzevitch M, Grab C, Greenshaw T, Grindhammer G, Haidt D, Henderson RCW, Hessler J, Hladký J, Hoffmann D, Horisberger R, Hreus T, Huber F, Jacobs PM, Jacquet M, Janssen T, Jung AW, Jung H, Kapichine M, Katzy J, Kiesling C, Klein M, Kleinwort C, Klest HT, Kogler R, Kostka P, Kretzschmar J, Krücker D, Krüger K, Landon MPJ, Lange W, Laycock P, Lee SH, Levonian S, Li W, Lin J, Lipka K, List B, List J, Lobodzinski B, Malinovski E, Martyn HU, Maxfield SJ, Mehta A, Meyer AB, Meyer J, Mikocki S, Mondal MM, Morozov A, Müller K, Nachman B, Naumann T, Newman PR, Niebuhr C, Nowak G, Olsson JE, Ozerov D, Park S, Pascaud C, Patel GD, Perez E, Petrukhin A, Picuric I, Pitzl D, Polifka R, Preins S, Radescu V, Raicevic N, Ravdandorj T, Reimer P, Rizvi E, Robmann P, Roosen R, Rostovtsev A, Rotaru M, Sankey DPC, Sauter M, Sauvan E, Schmitt S, Schmookler BA, Schoeffel L, Schöning A, Sefkow F, Shushkevich S, Soloviev Y, Sopicki P, South D, Spaskov V, Specka A, Steder M, Stella B, Straumann U, Sun C, Sykora T, Thompson PD, Traynor D, Tseepeldorj B, Tu Z, Valkárová A, Vallée C, Van Mechelen P, Wegener D, Wünsch E, Žáček J, Zhang J, Zhang Z, Žlebčík R, Zohrabyan H, Zomer F. Measurement of Lepton-Jet Correlation in Deep-Inelastic Scattering with the H1 Detector Using Machine Learning for Unfolding. Phys Rev Lett 2022; 128:132002. [PMID: 35426724 DOI: 10.1103/physrevlett.128.132002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 12/20/2021] [Accepted: 02/25/2022] [Indexed: 06/14/2023]
Abstract
The first measurement of lepton-jet momentum imbalance and azimuthal correlation in lepton-proton scattering at high momentum transfer is presented. These data, taken with the H1 detector at HERA, are corrected for detector effects using an unbinned machine learning algorithm (multifold), which considers eight observables simultaneously in this first application. The unfolded cross sections are compared with calculations performed within the context of collinear or transverse-momentum-dependent factorization in quantum chromodynamics as well as Monte Carlo event generators.
Collapse
Affiliation(s)
- V Andreev
- Lebedev Physical Institute, Moscow, Russia
| | - M Arratia
- University of California, Riverside, California 92521, USA
| | | | - A Baty
- Rice University, Houston, Texas 77005-1827, USA
| | - K Begzsuren
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
| | - A Belousov
- Lebedev Physical Institute, Moscow, Russia
| | - A Bolz
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - V Boudry
- LLR, Ecole Polytechnique, CNRS/IN2P3, Palaiseau, France
| | - G Brandt
- II. Physikalisches Institut, Universität Göttingen, Göttingen, Germany
| | - D Britzger
- Max-Planck-Institut für Physik, München, Germany
| | - A Buniatyan
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - L Bystritskaya
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - A J Campbell
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - K B Cantun Avila
- Departamento de Fisica Aplicada, CINVESTAV, Mérida, Yucatán, México
| | - K Cerny
- Joint Laboratory of Optics, Palacký University, Olomouc, Czech Republic
| | - V Chekelian
- Max-Planck-Institut für Physik, München, Germany
| | - Z Chen
- Shandong University, Shandong, People's Republic of China
| | - J G Contreras
- Departamento de Fisica Aplicada, CINVESTAV, Mérida, Yucatán, México
| | | | - J Cvach
- Institute of Physics, Academy of Sciences of the Czech Republic, Praha, Czech Republic
| | - J B Dainton
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - K Daum
- Fachbereich C, Universität Wuppertal, Wuppertal, Germany
| | - A Deshpande
- Stony Brook University, Stony Brook, New York 11794, USA
| | - C Diaconu
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - G Eckerlin
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - S Egli
- Paul Scherrer Institut, Villigen, Switzerland
| | - E Elsen
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - L Favart
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A Fedotov
- Institute for Theoretical and Experimental Physics, Moscow, Russia
| | - J Feltesse
- Irfu/SPP, CE Saclay, Gif-sur-Yvette, France
| | - M Fleischer
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - A Fomenko
- Lebedev Physical Institute, Moscow, Russia
| | - C Gal
- Stony Brook University, Stony Brook, New York 11794, USA
| | - J Gayler
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - L Goerlich
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | | | - M Gouzevitch
- Université Claude Bernard Lyon 1, CNRS/IN2P3, Villeurbanne, France
| | - C Grab
- Institut für Teilchenphysik, ETH, Zürich, Switzerland
| | - T Greenshaw
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | | | - D Haidt
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - R C W Henderson
- Department of Physics, University of Lancaster, Lancaster, United Kingdom
| | - J Hessler
- Max-Planck-Institut für Physik, München, Germany
| | - J Hladký
- Institute of Physics, Academy of Sciences of the Czech Republic, Praha, Czech Republic
| | - D Hoffmann
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | | | - T Hreus
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - F Huber
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - P M Jacobs
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - M Jacquet
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| | - T Janssen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A W Jung
- Department of Physics and Astronomy, Purdue University, West Lafayette, Indiana 47907, USA
| | - H Jung
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - M Kapichine
- Joint Institute for Nuclear Research, Dubna, Russia
| | - J Katzy
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - C Kiesling
- Max-Planck-Institut für Physik, München, Germany
| | - M Klein
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - C Kleinwort
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - H T Klest
- Stony Brook University, Stony Brook, New York 11794, USA
| | - R Kogler
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - P Kostka
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - J Kretzschmar
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - D Krücker
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - K Krüger
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - M P J Landon
- School of Physics and Astronomy, Queen Mary, University of London, London, United Kingdom
| | - W Lange
- Deutsches Elektronen-Synchrotron DESY, Zeuthen, Germany
| | - P Laycock
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - S H Lee
- University of Michigan, Ann Arbor, Michigan 48109, USA
| | - S Levonian
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - W Li
- Rice University, Houston, Texas 77005-1827, USA
| | - J Lin
- Rice University, Houston, Texas 77005-1827, USA
| | - K Lipka
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - B List
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - J List
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | | | | | - H-U Martyn
- I. Physikalisches Institut der RWTH, Aachen, Germany
| | - S J Maxfield
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - A Mehta
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | - A B Meyer
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - J Meyer
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - S Mikocki
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | - M M Mondal
- Stony Brook University, Stony Brook, New York 11794, USA
| | - A Morozov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - K Müller
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - B Nachman
- Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
| | - Th Naumann
- Deutsches Elektronen-Synchrotron DESY, Zeuthen, Germany
| | - P R Newman
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - C Niebuhr
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - G Nowak
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | - J E Olsson
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - D Ozerov
- Paul Scherrer Institut, Villigen, Switzerland
| | - S Park
- Stony Brook University, Stony Brook, New York 11794, USA
| | - C Pascaud
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| | - G D Patel
- Department of Physics, University of Liverpool, Liverpool, United Kingdom
| | | | - A Petrukhin
- Université Claude Bernard Lyon 1, CNRS/IN2P3, Villeurbanne, France
| | - I Picuric
- Faculty of Science, University of Montenegro, Podgorica, Montenegro
| | - D Pitzl
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - R Polifka
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - S Preins
- University of California, Riverside, California 92521, USA
| | - V Radescu
- Department of Physics, Oxford University, Oxford, United Kingdom
| | - N Raicevic
- Faculty of Science, University of Montenegro, Podgorica, Montenegro
| | - T Ravdandorj
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
| | - P Reimer
- Institute of Physics, Academy of Sciences of the Czech Republic, Praha, Czech Republic
| | - E Rizvi
- School of Physics and Astronomy, Queen Mary, University of London, London, United Kingdom
| | - P Robmann
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - R Roosen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - A Rostovtsev
- Institute for Information Transmission Problems RAS, Moscow, Russia
| | - M Rotaru
- Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering (IFIN-HH), Bucharest, Romania
| | - D P C Sankey
- STFC, Rutherford Appleton Laboratory, Didcot, Oxfordshire, United Kingdom
| | - M Sauter
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - E Sauvan
- LAPP, Université de Savoie, CNRS/IN2P3, Annecy-le-Vieux, France
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - S Schmitt
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - B A Schmookler
- Stony Brook University, Stony Brook, New York 11794, USA
| | | | - A Schöning
- Physikalisches Institut, Universität Heidelberg, Heidelberg, Germany
| | - F Sefkow
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - S Shushkevich
- Lomonosov Moscow State University, Skobeltsyn Institute of Nuclear Physics, Moscow, Russia
| | - Y Soloviev
- Lebedev Physical Institute, Moscow, Russia
| | - P Sopicki
- Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
| | - D South
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - V Spaskov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - A Specka
- LLR, Ecole Polytechnique, CNRS/IN2P3, Palaiseau, France
| | - M Steder
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - B Stella
- Dipartimento di Fisica Università di Roma Tre and INFN Roma 3, Roma, Italy
| | - U Straumann
- Physik-Institut der Universität Zürich, Zürich, Switzerland
| | - C Sun
- Shandong University, Shandong, People's Republic of China
| | - T Sykora
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - P D Thompson
- School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
| | - D Traynor
- School of Physics and Astronomy, Queen Mary, University of London, London, United Kingdom
| | - B Tseepeldorj
- Institute of Physics and Technology of the Mongolian Academy of Sciences, Ulaanbaatar, Mongolia
- Ulaanbaatar University, Ulaanbaatar, Mongolia
| | - Z Tu
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A Valkárová
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - C Vallée
- Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
| | - P Van Mechelen
- Inter-University Institute for High Energies ULB-VUB, Brussels and Universiteit Antwerpen, Antwerp, Belgium
| | - D Wegener
- Institut für Physik, TU Dortmund, Dortmund, Germany
| | - E Wünsch
- Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
| | - J Žáček
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | - J Zhang
- Shandong University, Shandong, People's Republic of China
| | - Z Zhang
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| | - R Žlebčík
- Faculty of Mathematics and Physics, Charles University, Praha, Czech Republic
| | | | - F Zomer
- IJCLab, Université Paris-Saclay, CNRS/IN2P3, Orsay, France
| |
Collapse
|
133
|
Nan N, Zuo HJ, Zhou Y, Zhang M, Zhang MD, Zhang DF, Tian JF, Gao BY, Nie XL, Liang LR, Lin J, Song XT. [Risk stratification and low-density lipoprotein cholesterol goal attainment rates in patients with very high-risk or extreme high-risk atherosclerotic cardiovascular diseases regarding three guidelines]. Zhonghua Nei Ke Za Zhi 2022; 61:377-383. [PMID: 35340183 DOI: 10.3760/cma.j.cn112138-20210529-00379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To explore the differences of risk stratification of very high-risk or extreme high-risk atherosclerotic cardiovascular diseases (ASCVD) and the attainment rates of low-density lipoprotein cholesterol (LDL-C) management targets evaluated by three different criteria, and the causal attributions of these differences. Methods: Patients with ASCVD were consecutively enrolled from January 1 to December 31 in 2019, and were evaluated for very high-risk or extreme high-risk and LDL-C goal attainment rates with 2018 American guideline on the management of blood cholesterol (2018AG), 2019 China Cholesterol Education Program (CCEP) Expert Advice for the management of dyslipidemias (2019EA) and 2020 Chinese expert consensus on lipid management of very high-risk ASCVD patients(2020EC), respectively. The causal attributions of the differences in attainment rates were analyzed as well. Results: A total of 1 864 ASCVD patients were included in this study. According to 2018AG, 2019EA and 2020EC, the proportions of the patients with very high-risk or extreme high-risk were 59.4%, 90.7%, and 65.6%, respectively. The absolute LDL-C target attainment rates were 37.2%, 15.7%, and 13.7%, respectively, the differences between each two rates were statistically significant (all P<0.001). As to the differences in attainment rates between 2020EC and 2018AG, 61.5% were due to the different LDL-C goal attainment values and 38.5% were caused by the different risk stratifications, while for the differences between 2020EC and 2019EA attainment rates, different LDL-C goal attainment values were responsible for 13.2%, and different risk stratifications were responsible for 86.8% of the differences. Conclusions: There are significant differences in the proportions and LDL-C attainment rates among the three different criteria for very high-risk or extreme high-risk ASCVD. 2020EC showed a moderate proportion of patients with extreme high-risk, and had the lowest LDL-C attainment rate. The differences between 2020EC and 2018AG are mainly due to the LDL-C target values, and the differences between 2020EC and 2019EA are mainly caused by the risk stratifications.
Collapse
Affiliation(s)
- N Nan
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
| | - H J Zuo
- Department of Community Health Research, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
| | - Y Zhou
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
| | - M Zhang
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
| | - M D Zhang
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
| | - D F Zhang
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
| | - J F Tian
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
| | - B Y Gao
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
| | - X L Nie
- Center for Clinical Epidemiology and Evidence-based Medicine, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - L R Liang
- Department of Clinical Epidemiology,Beijing Institute of Respiratory Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | - J Lin
- Department of Arteriosclerosis, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
| | - X T Song
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
| |
Collapse
|
134
|
Li SN, Lin J, Li CY, Dong JZ, Ma CS. [Prevention, early recognition and management of atrial esophageal fistula after catheter ablation for atrial fibrillation]. Zhonghua Xin Xue Guan Bing Za Zhi 2022; 50:298-301. [PMID: 35340152 DOI: 10.3760/cma.j.cn112148-20211229-01111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- S N Li
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China
| | - J Lin
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China
| | - C Y Li
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China
| | - J Z Dong
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China
| | - C S Ma
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing 100029, China
| |
Collapse
|
135
|
Wang DP, Lin J. Does Sports Industry Matter in Human Wellbeing: Evidence From China? Front Public Health 2022; 10:872506. [PMID: 35400061 PMCID: PMC8987153 DOI: 10.3389/fpubh.2022.872506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2022] [Accepted: 02/24/2022] [Indexed: 11/13/2022] Open
Abstract
It is widely considered that sport and physical activities contribute to the development of human wellbeing. It is a fact that sport brings positive energy, discipline, and human wellbeing. Sports have an enormous effect on human health. Therefore, we assess the effects of the sports industry on the human health of China by using the autoregressive distributed lag (ARDL) approach from 1998 to 2020. Findings show that sports activities significantly improve human health and wellbeing. Tourism has found a positive influence on health and helped to contribute to human wellbeing. Empirical results prove that health expenditure and financial development significantly increase the population health in China. China's government should focus on the sports and tourism industry to play an important role in human health and wellbeing.
Collapse
|
136
|
Lin Q, Zhou N, Zhu X, Lin J, Fang J, Gu F, Sun X, Wang Y. Outcomes of SBRT for lung oligo-recurrence of non-small cell lung cancer: a retrospective analysis. J Radiat Res 2022; 63:272-280. [PMID: 34958672 PMCID: PMC8944329 DOI: 10.1093/jrr/rrab118] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/24/2021] [Revised: 07/16/2021] [Indexed: 06/02/2023]
Abstract
The benefit of local ablative therapy (LAT) for oligo-recurrence has been investigated and integrated into the treatment framework. In recent decades, stereotactic body radiation therapy (SBRT) has been increasingly used to eliminate metastasis owing to its high rate of local control and low toxicity. This study aimed to investigate the outcomes of SBRT for patients with lung oligo-recurrence of non-small cell lung cancer (NSCLC) from our therapeutic center. Patients with lung oligo-recurrence of NSCLC treated with SBRT between December 2011 and October 2018 at Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) were reviewed. The characteristics, treatment-related outcomes, and toxicities of the patients were analyzed. Univariable and multivariable Cox regression were performed to identify the factors associated with survival. A total of 50 patients with lung oligo-recurrence of NSCLC were enrolled. The median follow-up period was 23.6 months. The 3-year local progression-free survival (LPFS), progression-free survival (PFS) and overall survival (OS) after SBRT were 80.2%, 21.9% and 45.3%, respectively. Patients in the subgroup with LAT to all residual diseases showed significantly improved OS and PFS. No treatment-related death occurred after SBRT. SBRT is a feasible option to treat patients with lung oligo-recurrence of NSCLC, with high rates of local control and low toxicity. LAT to all residual diseases was associated with better survival outcomes. Future prospective randomized clinical trials should evaluate SBRT strategies for such patients.
Collapse
Affiliation(s)
| | | | | | - Juan Lin
- Department of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, 1 Banshan Dong Road, Hangzhou, 310022, People’s Republic of China
| | - Jun Fang
- Department of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, 1 Banshan Dong Road, Hangzhou, 310022, People’s Republic of China
| | - Feiying Gu
- Department of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, 1 Banshan Dong Road, Hangzhou, 310022, People’s Republic of China
| | - Xiaojiang Sun
- Corresponding author. Department of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, 1 Banshan Dong Road, Hangzhou, 310022, People’s Republic of China. Telephone: (+86)13857196876; Fax: 086-571-88128162;
| | - Yuezhen Wang
- Department of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, 1 Banshan Dong Road, Hangzhou, 310022, People’s Republic of China
| |
Collapse
|
137
|
Wang XJ, Lin J, Bao XL, Liu X. [Senile intranodal palisaded myofibroblastoma: report of a case]. Zhonghua Bing Li Xue Za Zhi 2022; 51:240-242. [PMID: 35249291 DOI: 10.3760/cma.j.cn112151-20210616-00440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- X J Wang
- Department of Pathology, Weifang Heart Hospital, Weifang 261201, China
| | - J Lin
- Department of Pathology, Weifang Heart Hospital, Weifang 261201, China
| | - X L Bao
- Department of Pathology, Weifang Heart Hospital, Weifang 261201, China
| | - Xiaoli Liu
- Department of Clinical Laboratory, Weifang Heart Hospital, Weifang 261201, China
| |
Collapse
|
138
|
Zhao HR, Su BM, Shi YB, Lin J. Construction of Efficient Enzyme Systems for Preparing Chiral Ethyl 3-hydroxy-3-phenylpropionate. Enzyme Microb Technol 2022; 157:110033. [DOI: 10.1016/j.enzmictec.2022.110033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2022] [Revised: 03/12/2022] [Accepted: 03/18/2022] [Indexed: 11/03/2022]
|
139
|
Lin J, Fu Z, Yao J, Wei X, Wang D, Ning D, Chen M. Behavior of iron and other heavy metals in passivated sediments and the coupling effect on phosphorus. Sci Total Environ 2022; 808:152151. [PMID: 34875323 DOI: 10.1016/j.scitotenv.2021.152151] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/01/2021] [Revised: 11/28/2021] [Accepted: 11/29/2021] [Indexed: 06/13/2023]
Abstract
In situ passivation, which is easy to operate and affordable, is one of the most commonly used methods for sediment phosphorus (P) remediation. Understanding the behavior of iron and other heavy metals in passivated sediments is important for alleviating lake eutrophication and for ensuring drinking water safety. In this study, we investigated the behavior of P, Fe, Mn, Cd, Co, and Pb in lanthanum modified bentonite (LMB, Phoslock®) and polyaluminum chloride (PAC)-passivated sediments using intact sediment cores. Rhizon sampler and diffusive gradients in thin films technology (DGT) were respectively used to collect soluble and labile substances in sediment; a modified sequential selective extraction method was used to characterize metal forms. Results showed that LMB reduced soluble reactive phosphorus (SRP) at sediment depths of 0 ~ -15 mm and DGT-labile P flux at 0 ~ -50 mm. Correlation between DGT-labile P and Fe (R2 = 0.71) indicated that P mobility in the LMB group was affected by the behavior of Fe. PAC decreased SRP at sediment depths of 0, -5, -10, -15, -20, -25, and -50 mm with removal rates of 100%, 90%, 45%, 35%, 81%, 89%, and 100%, respectively. DGT-labile P flux was decreased by PAC at 0 ~ -10 mm and -50 ~ -110 mm, but increased at -10 ~ -50 mm; this is a result of synthetical effect by Al flocs adsorption and Fe(III) reductive dissolution. LMB decreased Cd, Co, and Pb in LMB layer in carbonate, reducible, and oxidizable forms. PAC decreased Cd mobility but caused the transformation of Co and Pb from reducible to other forms because of Fe(III) reductive dissolution. Those results indicate that sedimentary Fe plays an important role in in situ passivation. We suggest modifying passivators to Fe(II) adsorbents and increasing DO permeability of sediment to promote the formation of an Fe(III) passivation layer and hence the effectiveness of P control.
Collapse
Affiliation(s)
- Juan Lin
- School of Geographic Science, Nantong University, Nantong 226000, China
| | - Zhen Fu
- School of Chemical Engineering, Nanjing University of Science and Technology, Nanjing 210094, China
| | - Jiawen Yao
- School of Geographic Science, Nantong University, Nantong 226000, China
| | - Xiao Wei
- School of Geographic Science, Nantong University, Nantong 226000, China
| | - Dong Wang
- School of Geographic Science, Nantong University, Nantong 226000, China
| | - Dongliang Ning
- School of Geographic Science, Nantong University, Nantong 226000, China
| | - Musong Chen
- State Key Laboratory of Lake Science and Environment, Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences, Nanjing 210008, China.
| |
Collapse
|
140
|
DIAO X, Zheng Z, Yi C, Cao P, Ye H, Liu R, Lin J, Chen W, Mao H, Huang F, Yang X. POS-680 ASSOCIATION OF ABNORMAL IRON STATUS WITH THE OCCURRENCE AND PROGNOSIS OF PERITONEAL DIALYSIS-RELATED PERITONITIS. Kidney Int Rep 2022. [DOI: 10.1016/j.ekir.2022.01.714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
141
|
Lin J, Siddiqui M, Li E, Aguiar J, Ansbro B, Soliman M, Rich J, Alfaro J, Keeter M, Schaeffer E, Ross A. Factors Predicting Clinically Significant Prostate Cancer on PIRADS 3 lesions. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00551-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
142
|
LIU R, Ye H, Peng Y, Yi C, Lin J, Wu H, Diao X, Huang X, Mao H, Huang F, Yu X, Yang X. POS-702 INCREMENTAL PERITONEAL DIALYSIS WAS ASSOCIATED WITH BETTER SURVIVAL OUTCOMES AT THE INITIAL 6 YEARS OF PERITONEAL DIALYSIS: A PROPENSITY-MATCHED COHORT STUDY. Kidney Int Rep 2022. [DOI: 10.1016/j.ekir.2022.01.736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
143
|
Gao Y, Luo D, Wang Q, Lin J. Calcium and vitamin D supplementation in pre-eclampsia: Analysis of effectiveness and safety. TROP J PHARM RES 2022. [DOI: 10.4314/tjpr.v20i5.24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Purpose: To evaluate the impact of calcium and vitamin D (vit D) supplementation initiated at early pregnancy in high-risk women on reduction of preeclampsia risk.
Methods: This prospective cohort study involved 492 pregnant women who had experienced pre-eclampsia or eclampsia in their current pregnancy (high risk) and were either on calcium (1000 mg/day) as well as vit D (400 IU/day) supplementation at early pregnancy or none. All the included pregnant women received standard doses of calcium (1500 mg/day) and vit D (600 IU/day) supplementation post 20 gestation weeks till childbirth. The primary outcome was pre-eclampsia characterized by hypertension as well as proteinuria.
Results: From March 10, 2015 to February 24, 2018, each of the 246 pregnant women were assigned to the calcium/vit D group versus control group with no calcium/vit D. In the calcium/vit D group, 26.45 % developed preeclampsia compared to 32.11 % in control group with a Risk ratio [RR] of 0.82 (95 % confidence interval [CI], 0.62-1.08; p 0.167). No serious adverse events were related to calcium or vit D.
Conclusion: Calcium/vit D supplementation during early pregnancy did not demonstrate any significant reduction in pre-eclampsia. Large, high-quality studies with higher patient numbers are needed for adequate testing of impact of calcium/vit D on pre-eclampsia.
Collapse
|
144
|
Abstract
Objective: To investigate the clinical features, treatment and recurrence factors of intravenous leiomyomatosis (IVL) confined to the pelvic cavity after the operation. Methods: The clinical data of 81 patients who underwent surgery and were pathologically diagnosed with IVL at Women's Hospital, School of Medicine, Zhejiang University from January 2014 to March 2021, were analyzed retrospectively to explore the influencing factors of postoperative recurrence of IVL, including age, gravidity and parity, surgical methods, intraoperative conditions and so on. Results: (1) Clinical features: the age of 81 IVL patients was (43.9±8.1) years old; increased menstrual volume in 26 cases (32%, 26/81), prolonged menstrual period in 31 cases (38%, 31/81), frequency and urgency to urinate in 4 cases (5%, 4/81), abdominal pain and abdominal distension in 8 cases (10%, 8/81), and pelvic masses in 34 cases (42%, 34/81). IVL was diagnosed right in 4 of 72 patients (6%, 4/72) underwent preoperative ultrasound, right in 11 of 51 patients (22%, 11/51) underwent magnetic resonance imaging (MRI), and right in 4 of 19 patients (4/19) underwent CT. (2) Treatment: all patients with IVL underwent surgical treatment. Surgical procedure: myomectomy in 37 cases, total hysterectomy and bilateral salpingectomy in 19 cases, total hysterectomy and bilateral salpingo-ophorectomy in 25 cases. Surgical approach: hysteroscopic operation in 6 cases, transabdominal operation in 52 cases, laparoscopic operation in 23 cases. Fifty-three cases underwent rapid intraoperative pathological examination, 17 cases (32%, 17/53) of them were diagnosed right as IVL. (3) Influencing factors of IVL postoperative recurrence: among 81 patients with IVL, 3 cases were lost to follow-up, and 8 cases (10%, 8/78) had recurrence during follow-up. Age<35 years, number of pregnancies<2, number of births<2, number of fibroids ≥10, abnormal appearance of fibroids (long, vermicular, beadlike, cystic, etc.) and IVL invasion into adjacent vessels were all the risk factors influencing postoperative recurrence of IVL (all P<0.05). Methods of operation, ovariectomy or not, IVL invasion or not, maximum diameter of IVL, abundant blood vessels near uterine fibroids were not associated with postoperative recurrence of IVL (all P>0.05). Conclusions: The clinical manifestations and preoperative auxiliary examination of IVL are lack of specificity. Doctors need to pay attention to young patients with uterine fibroids, and choose the appropriate surgical scope when the characteristic manifestations of IVL be found during the operation, or the right diagnoses of IVL in the surgery's rapid intraoperative pathology be examined, and should remove the IVL lesions to reduce the recurrence as far as possible.
Collapse
Affiliation(s)
- X L Xia
- Department of Gynecology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China
| | - J Q Li
- Department of Gynecology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China
| | - J Lin
- Department of Gynecology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China
| |
Collapse
|
145
|
Wu X, Li Z, Lin J, Huang Z, Chen F. Engineered Cyclohexylamine Oxidase with Improved Activity and Stereoselectivity for Asymmetric Synthesis of a Bulky Dextromethorphan Precursor and Its Analogues. ChemCatChem 2022. [DOI: 10.1002/cctc.202101970] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Xiaofan Wu
- Fudan University Department of Chemistry CHINA
| | - Zhining Li
- Fudan University Department of Chemistry CHINA
| | - Juan Lin
- Fuzhou University College of Chemical Engineering CHINA
| | - Zedu Huang
- Fudan University Chemistry Department 220 Handan Road 200433 Shanghai CHINA
| | - Fener Chen
- Fudan University Department of Chemistry CHINA
| |
Collapse
|
146
|
Makower D, Qin J, Lin J, Xue X, Sparano JA. The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis. NPJ Breast Cancer 2022; 8:4. [PMID: 35027533 PMCID: PMC8758772 DOI: 10.1038/s41523-021-00368-9] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Accepted: 11/29/2021] [Indexed: 11/18/2022] Open
Abstract
The 21-gene recurrence score (RS) is prognostic for recurrence and predictive of chemotherapy benefit in early estrogen receptor-positive (ER +) HER2-negative (HER2-) breast cancer (BCA). We evaluated clinicopathologic characteristics, RS and chemotherapy benefit in invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and carcinomas of mixed histologies (ductal + lobular (DLC), ductal + other (DOC), lobular + other (LOC)). Women diagnosed between 1/1/2010 and 1/1/2014 with ER + HER2- BCA, measuring <5 cm, with 0–3 involved axillary nodes, surgery as first treatment, and available RS, were identified from the NCDB. Associations between categorical variables were examined using chi-square test. Cox proportional hazards model was used to examine overall survival (OS) differences among histology subtypes. IDC was associated with smaller size, high grade, and RS > 26. ILC was associated with larger size, and least likely to be high grade (p < 0.0001). Lobular histology was associated with lower incidence of RS > 26. IDC patients (pts) were more likely to receive chemotherapy than pts with other histologies (p < 0.0001). OS for IDC, ILC and DOC were similar. DLC was associated with improved OS (HR 0.82, p = 0.02). Adjuvant chemotherapy was associated with improved OS in IDC (HR = 0.76, p < 0.0001) but not in ILC (HR = 0.99, p = 0.93), DLC (HR = 1.04, p = 0.86), DOC (HR = 0.87, p = 0.71), or LOC (HR = 2.91, p = 0.10). Lobular and mixed BCA histologies have distinct clinicopathologic features compared with IDC, and are less likely to have high RS. OS is similar for IDC and ILC. Although chemotherapy benefit was seen only in IDC, benefit for ILC with RS > 26 cannot be excluded.
Collapse
Affiliation(s)
- Della Makower
- Montefiore Einstein Center for Cancer Care, New York, NY, USA.
| | - Jiyue Qin
- Albert Einstein Cancer Center, Bronx, NY, USA
| | - Juan Lin
- Albert Einstein Cancer Center, Bronx, NY, USA
| | - Xiaonan Xue
- Albert Einstein Cancer Center, Bronx, NY, USA
| | | |
Collapse
|
147
|
Lian X, Zhang X, Huang M, Lin J, Zeng J. [Genetic analysis of a case with 2q37 microdeletion syndrome]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2022; 39:81-84. [PMID: 34964974 DOI: 10.3760/cma.j.cn511374-20201020-00730] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
OBJECTIVE To diagnose and fine map a deletion in chromosome region 2q37. METHODS G-banded chromosomal karyotyping, multiplex ligation-dependent probe amplification (MLPA), single nucleotide polymorphism array (SNP-array), and fluorescence in situ hybridization (FISH) were carried out in conjunct for the analysis. RESULTS The patient was found to have karyotype of 46,XY,del(2)(q3?), MLPA revealed one copy number of both CAPN10-3 and ATG4B-7 genes from the 2q37.3 region, Both parents were found to be normal upon chromosome karyotyping and MLPA. SNP-array has found a 9.7 Mb deletion in the 2q37.1.37.3 region. FISH analysis has confirmed there is a single copy for 2q37.3. CONCLUSION Combination of MLPA, FISH and SNP-array have enabled accurate diagnosis for the patient, and also provided more clues for the correlation of genotype with the phenotype of the disease, and a basis for genetic counseling.
Collapse
Affiliation(s)
- Xiaohui Lian
- Laboratory of Basic Medicine, Dongfang Hospital (900th Hospital of Joint Logistics Support Force), Xiamen University, Fuzhou, Fujian 350025, China.
| | | | | | | | | |
Collapse
|
148
|
Xu Z, Zhang D, Lin J, Li X, Liu Y, Gao J, Xue Y, Zhang Y, Ding R, Huang G, Zhao T, Huang H, Gu C, Li W. The influence of CYP2R1 polymorphisms and gene-obesity interaction with hypertension risk in a Chinese rural population. Nutr Metab Cardiovasc Dis 2022; 32:241-248. [PMID: 34906413 DOI: 10.1016/j.numecd.2021.11.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Revised: 10/07/2021] [Accepted: 11/04/2021] [Indexed: 01/08/2023]
Abstract
BACKGROUND AND AIMS Several studies have reported that variants in CYP2R1 have been linked with an increased risk of hypertension. However, the interaction between CYP2R1 variants and environmental factors on the susceptibility of hypertension remained unclear. Therefore, this study evaluated the influence of CYP2R1 polymorphisms on hypertension susceptibility, and explored the interaction effect of CYP2R1 variations and obesity on the disease. METHODS AND RESULTS We included 766 incident hypertension cases matched with non-hypertension controls in a 1:1 ratio by sex, age (within 3 years). Two loci in CYP2R1 gene (rs10766197 and rs12794714) were genotyped by TaqMan probe assays. The concentration of 25-hydroxyvitamin-D was determined by human enzyme-linked immunosorbent assay (ELISA) kits. The associations of CYP2R1 polymorphisms and risks of vitamin D deficiency (VDD) were analyzed by logistic regression. Multifactor dimensionality reduction (MDR) was used to analyze the gene-environment interaction. Multiple logistic regression was used to examine the effect of CYP2R1 gene variations, and the interaction between CYP2R1 variation and obesity on hypertension susceptibility. The results showed that rs10766197 (GG vs. AA) and rs12794714 (GG vs. AA) polymorphisms were both associated with an increased risk of VDD (OR = 1.49, 95% confidence interval (CI) = 1.08-2.05 and OR = 1.63, 95% CI = 1.19-2.25, respectively), after adjustment for potential risk factors. We also found that rs12794714 polymorphism was significantly associated with elevated risk of hypertension under the dominant model (OR = 1.26, 95% CI = 1.01-1.56). In addition, the interactions between rs12794714 with both general obesity (OR = 3.93, 95% CI = 2.72-5.68) and central obesity (OR = 3.22, 95% CI = 2.29-4.52) have significant effects on hypertension susceptibility. CONCLUSIONS The study provided further evidence that CYP2R1 variation was associated with a higher risk of hypertension in Chinese rural population. The interaction between CYP2R1 rs12794714 and obesity may increase the risk of hypertension.
Collapse
Affiliation(s)
- Z Xu
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
| | - D Zhang
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
| | - J Lin
- Yidu Central Hospital of Weifang, Weifang, Shandong, PR China
| | - X Li
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
| | - Y Liu
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
| | - J Gao
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
| | - Y Xue
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
| | - Y Zhang
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
| | - R Ding
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
| | - G Huang
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
| | - T Zhao
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
| | - H Huang
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China
| | - C Gu
- The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, PR China.
| | - W Li
- Department of Nutrition and Food Hygiene, College of Public Health, Zhengzhou University, Zhengzhou, Henan, PR China.
| |
Collapse
|
149
|
Miao E, Zhang K, Liu J, Lin J, Yoo D, George CJ. Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study. Front Endocrinol (Lausanne) 2022; 13:1002834. [PMID: 36440189 PMCID: PMC9682011 DOI: 10.3389/fendo.2022.1002834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2022] [Accepted: 10/21/2022] [Indexed: 11/11/2022] Open
Abstract
INTRODUCTION Diabetes mellitus is a common comorbidity among patients with coronavirus disease 2019 (COVID-19). Diabetic patients with COVID-19 have a two-fold increased risk of death and tend to have more severe infection compared to the general population. Metformin, a first-line medication for diabetes management, has anti-inflammatory and immunomodulatory effects. Previous studies focusing on metformin and COVID-19 clinical outcomes have had mixed results, with some showing a mortality benefit or decreased complications with metformin use. To date, few studies have analyzed such outcomes among a diverse, multiracial community. METHODS This was a retrospective review of patients with Type 2 diabetes and a confirmed COVID-19 infection admitted to an urban academic medical center from January 1, 2020 to May 7, 2020. Baseline characteristics were collected. The primary outcomes of the study were in-hospital mortality and length of stay (LOS). RESULTS A total of 4462 patients with Type 2 diabetes and confirmed COVID-19 were identified. 41.3% were Black, and 41.5% were Hispanic. There were 1021 patients in the metformin group and 3441 in the non-metformin group. Of note, more participants in the metformin group had comorbid disease and/or advanced diabetes. We found no statistically significant differences between the metformin and non-metformin group in in-hospital mortality (28.1% vs 25.3%, P=0.08) or length of hospital stay in days (7.3 vs. 7.5, P=0.59), even after matching patients on various factors (29.3% vs. 29.6%, P=0.87; 7.7 vs. 8.1, P=0.23). CONCLUSION While patients had more comorbid disease and advanced diabetes in the metformin group, there were no significant differences with regard to in-hospital mortality or length of stay due to COVID-19 compared to the non-metformin group. Prospective studies are needed to determine if there is clinical benefit for initiating, continuing, or re-initiating metformin in patients hospitalized with COVID-19.
Collapse
Affiliation(s)
- Emily Miao
- Albert Einstein College of Medicine Bronx, New York, NY, United States
| | - Kaleena Zhang
- Albert Einstein College of Medicine Bronx, New York, NY, United States
| | - Jianyou Liu
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine Bronx, New York, NY, United States
| | - Juan Lin
- Department of Epidemiology and Population Health, Albert Einstein College of Medicine Bronx, New York, NY, United States
| | - Donna Yoo
- Albert Einstein College of Medicine Bronx, New York, NY, United States
| | - Claudene J. George
- Montefiore Medical Center, Division of Geriatrics, Albert Einstein College of Medicine Bronx, New York, NY, United States
- *Correspondence: Claudene J. George,
| |
Collapse
|
150
|
Xu L, Nie D, Su BM, Xu X, Lin J. A chemoenzymatic strategy for efficient synthesis of amphenicol antibiotic chloramphenicol mediated by an engineered L-threonine transaldolase with high activity and stereoselectivity. Catal Sci Technol 2022. [DOI: 10.1039/d2cy01670b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Chloramphenicol, a kind of amphenicol antibiotic with broad-spectrum antibacterial activity, is challenging for synthesis due to its stereochemistry. Here we designed a four-step chemoenzymatic strategy, including a biocatalytic step mediated...
Collapse
|